- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
NRX Pharmaceuticals Inc (NRXP)
NRX Pharmaceuticals Inc stock price live, this page displays NASDAQ NRXP stock exchange data. View the NRXP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the NRX Pharmaceuticals Inc real time stock price chart below.
What Is the NRX Pharmaceuticals Inc Stock Price Today?
The NRX Pharmaceuticals Inc stock price today is 2.640.
What Is the Stock Symbol for NRX Pharmaceuticals Inc?
The stock symbol for NRX Pharmaceuticals Inc is ""NRXP.""
What Stock Exchange Does NRX Pharmaceuticals Inc Trade On?
NRX Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is NRX Pharmaceuticals Inc a Good Stock to Buy?
Determining whether NRX Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NRXP quote. (ISIN: US6294442099)
What Is the NRX Pharmaceuticals Inc Stock Price Today?
The NRX Pharmaceuticals Inc stock price today is 2.640.
What Is the Stock Symbol for NRX Pharmaceuticals Inc?
The stock symbol for NRX Pharmaceuticals Inc is ""NRXP.""
What Stock Exchange Does NRX Pharmaceuticals Inc Trade On?
NRX Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is NRX Pharmaceuticals Inc a Good Stock to Buy?
Determining whether NRX Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NRXP quote. (ISIN: US6294442099)
NASDAQ
Currency in USD
2.640
-0.080(-2.94%)
Closed·
After Hours
2.710+0.070(+2.65%)
·
Fair Value
An estimate of a NRX Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.610
2.790
52 wk Range
1.100
6.010
NRXP Scorecard
Full Analysis
Net income is expected to grow this year
NRXP is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a NRX Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.6102.790
52 wk Range
1.1006.010
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NRXP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a NRX Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
31.667
Upside
+1,099.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- IBN Initiates Coverage of NRx Pharmaceuticals Inc.
- Investing.com
- IBN Initiates Coverage of NRx Pharmaceuticals Inc.
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
NRX Pharmaceuticals Inc Company Profile
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals Inc Earnings Call Summary for Q1/2025
- Net loss reduced to $5.5M in Q1 2025 from $6.5M in Q1 2024; company targets profitability by end of 2025
- NDA filed for NRx100 (ketamine-based treatment); FDA approvals for NRx100 and NRx101 expected in 2025
- Plans to expand clinic network and explore international markets; revenue from clinic operations anticipated before year-end
- Stock rose 5.73% in regular trading, fell 2.85% after hours; analyst price targets range from $18 to $46
- Cash and equivalents at $5.5M; InvestingPro notes weak margins and short-term obligations exceeding liquid assets
Last Updated: 15/05/2025, 22:30
Read Full TranscriptCompare NRXP to Peers and Sector
Metrics to compare | NRXP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNRXPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −0.8x | −0.5x | |
PEG Ratio | −0.05 | −0.01 | 0.00 | |
Price/Book | −1.8x | 2.6x | 2.6x | |
Price / LTM Sales | - | 2.4x | 3.3x | |
Upside (Analyst Target) | - | 90.1% | 42.8% | |
Fair Value Upside | Unlock | 3.0% | 6.5% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 31.667
(+1,099.50% Upside)
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-0.34 / -0.53
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does NRX Pharmaceuticals Trade On?
NRX Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for NRX Pharmaceuticals?
The stock symbol for NRX Pharmaceuticals is "NRXP."
What Is the NRX Pharmaceuticals Market Cap?
As of today, NRX Pharmaceuticals market cap is 45.64M.
What Is NRX Pharmaceuticals's Earnings Per Share (TTM)?
The NRX Pharmaceuticals EPS (TTM) is -1.92.
From a Technical Analysis Perspective, Is NRXP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has NRX Pharmaceuticals Stock Split?
NRX Pharmaceuticals has split 1 times.
How Many Employees Does NRX Pharmaceuticals Have?
NRX Pharmaceuticals has 0 employees.
What is the current trading status of NRX Pharmaceuticals (NRXP)?
As of 06 Aug 2025, NRX Pharmaceuticals (NRXP) is trading at a price of 2.64, with a previous close of 2.64. The stock has fluctuated within a day range of 2.61 to 2.79, while its 52-week range spans from 1.10 to 6.01.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.